New vaccine plant in Senegal gets 75 million euros from EIB

Published by
Reuters UK

DAKAR (Reuters) – The European Investment Bank (EIB) committed 75 million euros ($80 million) on Thursday to finance construction of a new facility in Senegal that will produce COVID-19 and other vaccines for use across Africa. The plant, run by the Dakar-based Institut Pasteur, is intended to help Africa reduce its dependence on vaccine imports, which currently account for 99% of the continent’s needs. It will produce vaccines against COVID-19, yellow fever and other endemic diseases. The EIB and the European Union had already donated 5 million euros in 2021 for feasibility studies and projec…

Read More

Share this Story
Load More Related Articles
Load More In Wall Street